Table 1.
Maternal characteristic of children with and without major congenital anomalies.
Table 2.
Maternal characteristics of children born to women with and without benzodiazepine prescriptions during the first trimester of pregnancy.
Table 3.
Absolute risks (per 10,000 children) of major congenital anomalies in children born to women with and without benzodiazepine prescriptions during the first trimester of pregnancy.
Table 4.
Association between benzodiazepine prescribing in the first trimester of pregnancy and the risk of major congenital anomalies in offspringa.
Table 5.
Association between benzodiazepine prescribing in the first trimester of pregnancy and the risk of major congenital anomalies in offspringa.
Table 6.
Sensitivity analyses with different definitions of drug exposures.